What is the best approach to help a 22-year-old patient with depression and anxiety quit smoking?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Smoking Cessation in a 22-Year-Old with Depression and Anxiety

Combine pharmacotherapy—specifically combination nicotine replacement therapy (21 mg patch plus 4 mg gum or lozenges) OR varenicline 1 mg twice daily—with at least 4 behavioral counseling sessions over 12 weeks. 1, 2

Why Combination Therapy is Essential

Pharmacotherapy alone without counseling may not be better than unaided cessation. 3, 1 The evidence is clear: counseling plus medication achieves a 15.2% quit rate compared to only 8.6% with brief advice alone. 1 Population-level studies demonstrate that counseling by a smoking cessation specialist plus medication results in significant improvement in cessation rates (OR = 3.25; CI, 2.05–5.15). 3

First-Line Pharmacotherapy Options

Choose one of these evidence-based regimens:

Option 1: Combination Nicotine Replacement Therapy (Preferred for Depression/Anxiety)

  • 21 mg nicotine patch daily PLUS 4 mg nicotine gum or lozenges as needed 1, 4
  • This combination achieves a 36.5% abstinence rate at 6 months—the highest rate among all treatment combinations 1
  • Increases abstinence rates from approximately 10% to 17% 4
  • Safe even in patients with cardiovascular disease, with no evidence of increased cardiac events 1

Option 2: Varenicline

  • Start 1-2 weeks before quit date 4, 5
  • Titration schedule: Days 1-3: 0.5 mg once daily; Days 4-7: 0.5 mg twice daily; Day 8 onward: 1 mg twice daily 5
  • Most effective single agent, increasing quit rates from 12% to 28% in placebo-controlled trials 4
  • Important caveat: FDA labeling warns of neuropsychiatric adverse events including changes in mood, depression, mania, anxiety, and suicidal ideation 5—this is particularly relevant for your 22-year-old patient with existing depression and anxiety

Given the depression and anxiety comorbidity, combination NRT is the safer initial choice over varenicline. 1, 5

Required Behavioral Support Component

Minimum of 4 counseling sessions over 12 weeks, with the first session within 2-3 weeks of starting medication. 3, 1, 2

Session Structure

  • Duration: 10-30+ minutes per session (longer sessions linked to higher success rates) 3, 2
  • Dose-response relationship exists: More or longer sessions improve cessation rates, with benefits plateauing after 90 minutes of total contact time 3

Use the 5 A's Framework at Every Visit

  1. Ask about tobacco use at every visit 3, 2
  2. Advise all tobacco users to quit in a clear, strong, personalized manner 3, 2
  3. Assess willingness to make a quit attempt 3, 2
  4. Assist with the quit attempt using counseling and pharmacotherapy 3, 2
  5. Arrange follow-up contact 3, 2

Core Counseling Content

  • Help identify smoking triggers and high-risk situations 2
  • Develop coping strategies for nicotine withdrawal symptoms (which peak within 1-2 weeks after quitting, then subside) 3, 1, 4
  • Provide problem-solving skills training for difficult situations where smoking is likely 3, 2
  • Use motivational interviewing principles: Express empathy, develop discrepancy, roll with resistance, and support self-efficacy 3, 2, 4

Special Considerations for Depression and Anxiety

There is a high incidence of depression, anxiety, and stress in smokers, all of which are common causes of relapse. 3 Consider referral to specialized smoking cessation programs with staff trained to treat mental health disorders, or to behavior therapists with expertise in treating comorbid substance dependence and mental health disorders. 3

Emerging evidence suggests that stopping smoking may actually improve mental health, with improvements potentially equal to taking antidepressants. 6 Smoking may cause some mental health problems, and the tobacco withdrawal cycle partly contributes to worse mental health. 6

Treatment Duration and Follow-Up

  • Initial treatment course: 12 weeks 1, 2, 5
  • First follow-up: Within 2 weeks of starting pharmacotherapy 2, 4
  • For successful quitters at 12 weeks: Recommend an additional 12-week course to further increase likelihood of long-term abstinence 5
  • Ongoing monitoring: Minimum 12-week intervals during treatment 4

If Initial Treatment Fails

Do not give up—tobacco dependence is a chronic condition requiring repeated intervention. 7

Algorithm for Treatment Failure

  1. If combination NRT fails: Resume or continue combination NRT with intensified behavioral therapy, OR switch to varenicline 4
  2. If varenicline fails: Resume varenicline with intensified behavioral therapy, OR switch to combination NRT plus bupropion 4
  3. Try a first-line medication not previously used 3, 1
  4. Consider longer course of treatment (extending to 6 months or 1 year) 2

Common Pitfalls to Avoid

  • Insufficient follow-up: Patients need ongoing support, not just initial prescription 2, 4
  • Inadequate counseling duration: Brief advice alone achieves only 8.6% quit rate versus 15.2% with counseling plus medication 1
  • Pharmacotherapy without counseling: This negates much of the benefit 1, 2
  • Ignoring comorbid depression and anxiety: These are common causes of relapse and must be addressed 3, 2, 4
  • Single-session approach: At least 4 sessions are needed 2
  • Premature discontinuation: Encourage patients to persist through the 1-2 week withdrawal peak 1, 4

Practical Implementation for Your 22-Year-Old Patient

  1. Set a quit date within the next 1-2 weeks 5
  2. Start combination NRT: 21 mg patch daily + 4 mg gum/lozenges as needed (safer than varenicline given depression/anxiety) 1, 5
  3. Schedule 4 counseling sessions over 12 weeks, first within 2-3 weeks 1, 2
  4. Screen and monitor depression/anxiety symptoms throughout treatment 3, 2
  5. Provide self-help materials and consider quitline referral (1-800-QUIT-NOW) as supplementary support 2
  6. Plan for 12-week initial course, with additional 12 weeks if successful 5

The rate of successful smoking cessation at 1 year is only 3-5% when patients simply try to stop, 7-16% with behavioral intervention alone, but up to 24% when receiving pharmacological treatment and behavioral support. 7

References

Guideline

Effective Options for Quitting Nicotine in Patients with Depression and Anxiety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Effective Smoking Cessation Counseling Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Smoking Cessation Treatment Options

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the most effective treatments for smoking cessation?
What is the most appropriate smoking cessation therapy for a 45-year-old male with a history of heavy smoking (two packs per day) and a recent ST-segment elevation myocardial infarction (STEMI), who is ready to quit smoking and has a medical history that includes medications such as atorvastatin, valsartan, metoprolol succinate, aspirin, and clopidogrel?
What is the best approach for a 45-year-old male with a recent Cerebrovascular Accident (CVA) and Transient Ischemic Attack (TIA) to quit smoking?
What is the recommended protocol for smoking cessation in a 48-year-old male patient?
What is the treatment for a 61-year-old patient with emphysema who smokes?
What is the best treatment option for an elderly female patient with osteoporosis findings on a Dual-Energy X-ray Absorptiometry (DEXA) scan?
Does levofloxacin (Levaquin) cover atypical pathogens, Klebsiella pneumoniae, and Pseudomonas aeruginosa in an older adult patient with cavitary pneumonia and potential underlying health conditions?
What is the recommended treatment for a 34-year-old female with ringworm (tinea infection) on the skin of her thumb?
Is a statin (HMG-CoA reductase inhibitor) used to treat hypertriglyceridemia?
What are the indications and recommendations for off-pump total arterial revascularization (off-pump CABG) in patients with coronary artery disease, particularly those with multiple vessel disease, diabetes, or high risk for complications from cardiopulmonary bypass?
Is Bactrim DS (sulfamethoxazole and trimethoprim) a suitable treatment option for a patient with a skin wound suspected of being infected with bacteria?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.